Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer, improving outcomes in patients with advanced malignancies. The use of ICIs in clinical practice, and the number of ICI clinical trials, are rapidly increasing. The use of ICIs in combination with other forms of cancer t...
Saved in:
| Main Authors: | Sean Khozin, Elad Sharon, Michael Dougan, Osama Rahma, Douglas B Johnson, Leyre Zubiri, Meghan E Sise, Shaily Arora, Ravikumar Komandur Elayavilli, Aakanksha Khandelwal, Mace Rothenberg, Laura Petrillo, Alexandra-Chloe Villani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-07-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/9/7/e002896.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic utility of CT for suspected immune checkpoint inhibitor enterocolitis
by: Michael Dougan, et al.
Published: (2020-10-01) -
Pericardial disease in patients treated with immune checkpoint inhibitors
by: Anju Nohria, et al.
Published: (2021-06-01) -
Immune checkpoint inhibitor-associated celiac disease
by: Jonathan Chen, et al.
Published: (2020-05-01) -
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis
by: Sandra M Herrmann, et al.
Published: (2023-01-01) -
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors
by: Andrew L Mammen, et al.
Published: (2021-07-01)